The mesentery: structure, function, and role in disease

The Lancet Gastroenterology and Hepatology

Volumn 1, Issue 3, 2016, Pages 238-247

  Coffey, J Calvin ^a   O'Leary, D Peter ^a  

^a UNIVERSITY HOSPITAL LIMERICK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIA; HUMAN; INTESTINE; INTESTINE VOLVULUS; MESENTERY; MESENTERY CYST; MESOCOLON; PERITONEAL CAVITY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; ANATOMY AND HISTOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEAL DISEASE;

HUMANS; MESENTERY; PERITONEAL DISEASES;

EID: 84996486989     PISSN: 24681253     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2468-1253(16)30026-7     Document Type: Review

References (101)

1. 1 Coffey, JC, Dillon, M, Sehgal, R, et al. Mesenteric-based surgery exploits gastrointestinal, peritoneal, mesenteric and fascial continuity from duodenojejunal flexure to the anorectal junction—a review. Dig Surg 32 (2015), 291–300.
2. 2 Sehgal, R, Coffey, JC, Historical development of mesenteric anatomy provides a universally applicable anatomic paradigm for complete/total mesocolic excision. Gastroenterol Rep 2 (2014), 245–250.
3. 3 Toldt, C, Rosa, AD, Bau und Wachstumsveranterungen der Gekrose des menschlischen Darmkanales. Denkschrdmathnaturwissensch 41 (1879), 1–56.
4. 4 Toldt, C, Rosa, AD, An atlas of human anatomy for students and physicians, 1926, Macmillan, New York, NY.
5. 5 Toldt, C, An atlas of human anatomy for students and physicians, revised edition, 1919, Rebman, New York, NY, 407–409.
6. 6 Treves, F, Lectures on the anatomy of the intestinal canal and peritoneum in man. BMJ 1 (1885), 580–583.
7. 7 Treves, F, Discussion on the subsequent course and later history of cases of appendicitis after operation. Med Chir Trans 88 (1905), 429–610.
8. 8 McConnell, AA, Garratt, TH, Abnormalities of fixation of the ascending colon: the relation of symptoms to anatomical findings. Br J Surg 10 (1923), 532–557.
9. 9 Netter, FH, Atlas of human anatomy, 2014, Elsevier Health Sciences, Philadelphia, PA.
10. 10 Standring, S, Gray's anatomy: the anatomical basis of clinical practice, 2015, Elsevier Health Sciences, London.
11. 11 Trebješanin, Z, Babić, S, Vučurević, G, Popov, P, Ilijevski, N, Blagotić, M, Persistent descending mesocolon: case report. Srp Arh Celok Lek 140 (2012), 637–640 (in Serbian).
12. 12 Vyas, KC, Joshi, CP, Misra, S, Volvulus of descending colon with anomalous mesocolon. Indian J Gastroenterol 16 (1997), 34–35.
13. 13 Tsuruta, A, Kawai, A, Oka, Y, et al. Laparoscopic right hemicolectomy for ascending colon cancer with persistent mesocolon. World J Gastroenterol 20 (2014), 5557–5560.
14. 14 Ellis, H, Mahadevan, V, Clinical anatomy: applied anatomy for students and junior doctors, 2013, Wiley, Chichester.
15. 15 Balthazar, EJ, Congenital positional anomalies of the colon: radiographic diagnosis and clinical implications. Abnormalities of fixation. Gastrointest Radiol 2 (1977), 49–56.
16. 16 Popky, GL, Lapayowker, MS, Persistent descending mesocolon. Radiology 86 (1966), 327–331.
17. 17 Morgenstern, L, Persistent descending mesocolon. Surg Gynecol Obstet 110 (1960), 197–202.
18. 18 Kanai, M, Tokunaga, T, Miyaji, T, Colonic varices as a result of persistent mesocolon of the ascending and descending colon. Endoscopy 43 (2011), E103–E104.
19. 19 Culligan, K, Coffey, JC, Kiran, RP, Kalady, M, Lavery, IC, Remzi, FH, The mesocolon: a prospective observational study. Colorectal Dis 14 (2012), 421–428.
20. 20 Culligan, K, Walsh, S, Dunne, C, et al. The mesocolon: a histological and electron microscopic characterization of the mesenteric attachment of the colon prior to and after surgical mobilization. Ann Surg 260 (2014), 1048–1056.
21. 21 Coffey, JC, Culligan, K, Walsh, LG, et al. An appraisal of the computed axial tomographic appearance of the human mesentery based on mesenteric contiguity from the duodenojejunal flexure to the mesorectal level. Eur Radiol 26 (2016), 714–721.
22. 22 Culligan, K, Remzi, FH, Soop, M, Coffey, JC, Review of nomenclature in colonic surgery—proposal of a standardised nomenclature based on mesocolic anatomy. Surgeon 11 (2013), 1–5.
23. 23 Coffey, JC, Sehgal, R, Culligan, K, et al. Terminology and nomenclature in colonic surgery: universal application of a rule-based approach derived from updates on mesenteric anatomy. Tech Coloproctol 18 (2014), 789–794.
24. 24 Walsh, LG, Kenny, BJ, El Bassiouni, M, Coffey, JC, Cancer arising from the remnant mucosa of the ileoanal anastomosis leading to pouchectomy. BMJ Case Rep, 2016, 10.1136/bcr-2015-212802 published online Aug 1.
25. 25 Sehgal, R, Coffey, JC, The development of consensus for complete mesocolic excision (CME) should commence with standardisation of anatomy and related terminology. Int J Colorectal Dis 29 (2014), 763–764.
26. 26 Sehgal, R, Coffey, JC, Standardization of the nomenclature based on contemporary mesocolic anatomy is paramount prior to performing a complete mesocolic excision. Int J Colorectal Dis 29 (2014), 543–544.
27. 27 Coffey, JC, Dockery, P, Colorectal cancer: surgery for colorectal cancer—standardization required. Nat Rev Gastroenterol Hepatol 13 (2016), 256–257.
28. 28 Feng, B, Sun, J, Ling, TL, et al. Laparoscopic complete mesocolic excision (CME) with medial access for right-hemi colon cancer: feasibility and technical strategies. Surg Endosc 26 (2012), 3669–3675.
29. 29 Siani, L M, Pulica, C, Laparoscopic complete mesocolic excision with central vascular ligation in right colon cancer: long-term oncologic outcome between mesocolic and non-mesocolic planes of surgery. Scand J Surg 104 (2015), 219–226.
30. 30 Dimitriou, N, Griniatsos, J, Complete mesocolic excision: techniques and outcomes. World J Gastrointest Oncol 7 (2015), 383–388.
31. 31 Mori, S, Kita, Y, Baba, K, Laparoscopic complete mesocolic excision via reduced port surgery for treatment of colon cancer. Dig Surg 32 (2015), 45–51.
32. 32 Liang, J, Fazio, V, Lavery, I, et al. Primacy of surgery for colorectal cancer. Br J Surg 102 (2015), 847–852.
33. 33 Bertelsen, CA, Neuenschwander, AU, Jansen, JE, Short-term outcomes after complete mesocolic excision compared with ‘conventional’ colonic cancer surgery. Br J Surg 103 (2016), 581–589.
34. 34 Coffey, JC, O'Leary, DP, Kiernan, MG, Faul, P, The mesentery in Crohn's disease: friend or foe?. Curr Opin Gastroenterol 32 (2016), 267–273.
35. 35 Zuo, L, Li, Y, Zhu, W, et al. Mesenteric adipocyte dysfunction in Crohn's disease is associated with hypoxia. Inflamm Bowel Dis 22 (2016), 114–126.
36. 36 Loskutoff, DJ, Samad, F, The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 18 (1998), 1–6.
37. 37 Bonen, A, Tandon, NN, Glatz, JF, Luiken, JJ, Heigenhauser, GJ, The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes. Int J Obes 30 (2006), 877–883.
38. 38 Coffey, JC, Surgical anatomy and anatomic surgery—clinical and scientific mutualism. Surgeon 11 (2013), 177–182.
39. 39 Healy, DA, Murphy, SP, Burke, JP, Coffey, JC, Artificial interfaces (“AI”) in surgery: historic development, current status and program implementation in the public health sector. Surg Oncol 22 (2013), 77–85.
40. 40 Kluth, D, Jaeschke-Melli, S, Fiegel, H, The embryology of gut rotation. Semin Pediatr Surg 12 (2003), 275–279.
41. 41 Beck, DE, Nasseri, Y, Hull, TL, et al. (eds.) The ASCRS manual of colon and rectal surgery, 2014, Springer, New York, NY.
42. 42 Cochard, LR, Netter's atlas of human embryology: updated edition, 2012, Elsevier Health Sciences, London.
43. 43 Moore, KL, Persaud, TVN, The developing human: clinically oriented embryology, 2003, Saunders, Philadelphia, PA.
44. 44 Sadler, TW, Langman's medical embryology, 2011, Wolters Kluwer Health, Philadelphia, PA.
45. 45 Schoenwolf, GC, Bleyl, SB, Brauer, PR, Larsen's human embryology, 2014, Elsevier Health Sciences, Philadelphia, Philadelphia, PA.
46. 46 Wang, GJ, Gao, CF, Wei, D, Wang, C, Meng, WJ, Anatomy of the lateral ligaments of the rectum: a controversial point of view. World J Gastroenterol 16 (2010), 5411–5415.
47. 47 Culligan, K, Sehgal, R, Mulligan, D, et al. A detailed appraisal of mesocolic lymphangiology—an immunohistochemical and stereological analysis. J Anat 225 (2014), 463–472.
48. 48 Walsh, LG, O'Leary, DP, Coffey, JC, The mesocolic hilum: an electron microscopic appraisal of anatomy. Irish J Med Sci, 185, 2016, s97.
49. 49 Sakuraba, A, Sato, T, Kamada, N, Kitazume, M, Sugita, A, Hibi, T, Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137 (2009), 1736–1745.
50. 50 Magnusson, FC, Liblau, RS, von Boehmer, H, et al. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology 134 (2008), 1028–1037.
51. 51 Burke, JP, Cunningham, MF, Watson, RW, Docherty, NG, Coffey, JC, O'Connell, PR, Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts. Br J Surg 97 (2010), 1126–1134.
52. 52 Burke, JP, Watson, RW, Mulsow, JJ, Docherty, NG, Coffey, JC, O'Connell, PR, Endoglin negatively regulates transforming growth factor β1-induced profibrotic responses in intestinal fibroblasts. Br J Surg 97 (2010), 892–901.
53. 53 Peyrin-Biroulet, L, Gonzalez, F, Dubuquoy, L, et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease. Gut 61 (2012), 78–85.
54. 54 Li, Y, Wang, J, Asahina, K, Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci USA 110 (2013), 2324–2329.
55. 55 Blackburn, SC, Stanton, MP, Anatomy and physiology of the peritoneum. Semin Pediatr Surg 23 (2014), 326–330.
56. 56 Burzynski, G, Shepherd, IT, Enomoto, H, Genetic model system studies of the development of the enteric nervous system, gut motility and Hirschsprung's disease. Neurogastroenterol Motil 21 (2009), 113–127.
57. 57 Nishiyama, C, Uesaka, T, Manabe, T, et al. Trans-mesenteric neural crest cells are the principal source of the colonic enteric nervous system. Nat Neurosci 15 (2012), 1211–1218.
58. 58 Oldenburg, WA, Lau, LL, Rodenberg, TJ, Edmonds, HJ, Burger, CD, Acute mesenteric ischemia: a clinical review. Arch Intern Med 164 (2004), 1054–1062.
59. 59 Berland, T, Oldenburg, WA, Acute mesenteric ischemia. Curr Gastroenterol Rep 10 (2008), 341–346.
60. 60 Akram, S, Pardi, DS, Schaffner, JA, Smyrk, TC, Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin Gastroenterol Hepatol 5 (2007), 589–596.
61. 61 Medappil, N, Reghukumar, R, Sandwich sign in mesenteric lymphoma. J Cancer Res Ther 6 (2010), 403–404.
62. 62 Zhang, KR, Jia, HM, Mesenteric Castleman disease. J Pediatr Surg 43 (2008), 1398–1400.
63. 63 Park, IS, Kye, BH, Kim, HS, et al. Primary mesenteric carcinoid tumor. J Korean Surg Soc 84 (2013), 114–117.
64. 64 Li, C, Kuemmerle, JF, Mechanisms that mediate the development of fibrosis in patients with Crohn's disease. Inflamm Bowel Dis 20 (2014), 1250–1258.
65. 65 Salemis, NS, Gourgiotis, S, Tsiambas, E, Karagkiouzis, G, Nakos, G, Karathanasis, V, Diffuse large B cell lymphoma of the mesentery: an unusual presentation and review of the literature. J Gastrointest Cancer 40 (2009), 79–82.
66. 66 Kulaylat, AN, Hollenbeak, CS, Sangster, W, Stewart, DB Sr, Impact of smoking on the surgical outcome of Crohn's disease: a propensity-score matched National Surgical Quality Improvement Program analysis. Colorectal Dis 17 (2015), 891–902.
67. 67 Han, H, Kim, H, Rehman, A, Jang, SM, Paik, SS, Appendiceal Crohn's disease clinically presenting as acute appendicitis. World J Clin Cases 2 (2014), 888–892.
68. 68 Kredel, LI, Siegmund, B, Adipose-tissue and intestinal inflammation—visceral obesity and creeping fat. Front Immunol, 5, 2014, 462.
69. 69 Sazuka, S, Katsuno, T, Nakagawa, T, et al. Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease. Dig Dis Sci 59 (2014), 760–768.
70. 70 Jain, P, Motwani, R, Morphological variations of superior mesenteric artery: a cadaveric study. Int J Anat Res 1 (2013), 83–87.
71. 71 Bhandarwar, AH, Tayade, MB, Borisa, AD, Kasat, GV, Laparoscopic excision of mesenteric cyst of sigmoid mesocolon. J Minim Access Surg 9 (2013), 37–39.
72. 72 Reddy, GR, Gunadal, S, Banda, VR, Banda, NR, Infected mesenteric cyst. BMJ Case Rep, 2013, 10.1136/bcr-2012-008195 published online April 18.
73. 73 Stone, JH, Zen, Y, Deshpande, V, IgG4-related disease. N Engl J Med 366 (2012), 539–551.
74. 74 Bala, A, Coderre, SP, Johnson, DR, Nayak, V, Treatment of sclerosing mesenteritis with corticosteroids and azathioprine. Can J Gastroenterol 15 (2001), 533–535.
75. 75 Nomura, Y, Kamisawa, T, Tabata, T, et al. A case of IgG4-related sclerosing mesenteritis. Pathol Res Pract 207 (2011), 518–521.
76. 76 Wilkes, A, Griffin, N, Dixon, L, Dobbs, B, Frizelle, FA, Mesenteric panniculitis: a paraneoplastic phenomenon?. Dis Colon Rectum 55 (2012), 806–809.
77. 77 Gogebakan, O, Albrecht, T, Osterhoff, MA, Reimann, A, Is mesenteric panniculitis truly a paraneoplastic phenomenon? A matched pair analysis. Eur J Radiol 82 (2013), 1853–1859.
78. 78 Boni, L, Benevento, A, Dionigi, G, Rovera, F, Diurni, M, Dionigi, R, Injection of colorectal cancer cells in mesenteric and antimesenteric sides of the colon results in different patterns of metastatic diffusion: an experimental study in rats. World J Surg Oncol, 3, 2005, 69.
79. 79 Kaplan, GG, Pederson, BV, Andersson, RE, Sands, BE, Korzenik, J, Frisch, M, The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut 56 (2007), 1387–1392.
80. 80 Sahebally, SM, Burke, JP, Chang, KH, Kiernan, MG, O'Connell, PR, Coffey, JC, Circulating fibrocytes and Crohn's disease. Br J Surg 100 (2013), 1549–1556.
81. 81 Schaffler, A, Scholmerich, J, Buchler, C, Mechanisms of disease: adipocytokines and visceral adipose tissue—emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2 (2005), 103–111.
82. 82 Rethorst, CD, Bernstein, I, Trivedi, MH, Inflammation, obesity, and metabolic syndrome in depression: analysis of the 2009–2010 National Health and Nutrition Examination Survey (NHANES). J Clin Psychiatry 75 (2014), e1428–e1432.
83. 83 Yang, YK, Chen, M, Clements, RH, Abrams, GA, Aprahamian, CJ, Harmon, CM, Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes. Cell Physiol Biochem 22 (2008), 531–538.
84. 84 Sen, D, Ghosh, S, Roy, D, Correlation of C-reactive protein and body mass index with diabetic retinopathy in Indian population. Diabetes Metab Syndr 9 (2015), 28–29.
85. 85 Oliphant, M, Berne, AS, Computed tomography of the subperitoneal space: demonstration of direct spread of intraabdominal disease. J Comput Assist Tomogr 6 (1982), 1127–1137.
86. 86 Dodds, WJ, Darweesh, RM, Lawson, TL, et al. The retroperitoneal spaces revisited. Am J Roentgenol 147 (1986), 1155–1161.
87. 87 Byrnes, KG, O'Leary, DP, Coffey, JC, Endocolonic ultrasound mapping of the mesocolon and its mesenteric attachments: a proof of concept. Irish J Med Sci, 185(suppl 2), 2016, 57.
88. 88 Jamieson, JK, Dobson, JF, Lymphatics of the colon: with special reference to the operative treatment of cancer of the colon. Ann Surg 50 (1909), 1077–1090.
89. 89 Miles, WE, A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. CA Cancer J Clin 21 (1971), 361–364.
90. 90 Heald, RJ, Husband, EM, Ryall, RD, The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?. Br J Surg 69 (1982), 613–616.
91. 91 Hohenberger, W, Weber, K, Matzel, K, et al. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Colorectal Dis 11 (2009), 354–364.
92. 92 Desreumaux, P, Ernst, O, Geboes, K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 117 (1999), 73–81.
93. 93 Kaser, A, Tilg, H, “Metabolic aspects” in inflammatory bowel diseases. Curr Drug Deliv 9 (2012), 326–332.
94. 94 Qiu, Y, Mao, R, Chen, BL, He, Y, Zeng, ZR, Chen, MH, Systematic review with meta-analysis of prospective studies: anti-tumour necrosis factor for prevention of postoperative Crohn's disease recurrence. J Crohns Colitis 9 (2015), 918–927.
95. 95 Parkes, GC, Whelan, K, Lindsay, JO, Smoking in inflammatory bowel disease: impact on disease course and insights into the aetiology of its effect. J Crohns Colitis 8 (2014), 717–725.
96. 96 Clemente, TR, Dos Santos, AN, Sturaro, JN, et al. Infliximab modifies mesenteric adipose tissue alterations and intestinal inflammation in rat-s with TNBS-induced colitis. Scand J Gastroenterol 47 (2012), 943–950.
97. 97 Batra, A, Heimesaat, MM, Bereswill, S, et al. Mesenteric fat-control site for bacterial translocation in colitis?. Mucosal Immunol 5 (2012), 580–591.
98. 98 Drouet, M, Dubuquoy, L, Desreumaux, P, Bertin, B, Visceral fat and gut inflammation. Nutrition 28 (2012), 113–117.
99. 99 Needham, BL, Kim, C, Mukherjee, B, Bagchi, P, Stanczyk, FZ, Kanaya, AM, Endogenous sex steroid hormones and glucose in a South-Asian population without diabetes: The Metabolic Syndrome and Atherosclerosis in South-Asians Living in America pilot study. Diabet Med 32 (2015), 1193–1200.
100. 100 Nazare, JA, Smith, J, Borel, AL, et al. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA Study). Am J Cardiol 115 (2015), 307–315.
101. 101 Tracy, RP, Is visceral adiposity the “enemy within”?. Arterioscler Thromb Vasc Biol 21 (2001), 881–883.